Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Where's the news on TH1902?

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Mar 30, 2023 10:43am

69 Views

Post# 35369114

RE:RE:RE:Where's the news on TH1902?

Hey April 1 is a saterday so we can hope they won't put out a PR on that day.... not exactly the best day to build credibility. They must have used Friday the 13th before. I recall October 1st (Holllween) a few years ago was a real ripper.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec